Noroseal 2.6 g Intramammary Suspension for Cattle
Noroseal 2.6 g Intramammary Suspension for Cattle
Authorised
- Bismuth subnitrate, heavy
Product identification
Medicine name:
Noroseal 2.6 g Intramammary Suspension for Cattle
Intraseal 2,6 g, intramaminė suspensija galvijams
Active substance:
- Bismuth subnitrate, heavy
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Bismuth subnitrate, heavy2.60gram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal0day
-
Milk0hour
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG52X
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Low density polyethylene syringe with a smooth tapered hermetically sealed nozzle. Pack sizes: Buckets of 120 syringes including 120 individually wrapped teat cleaning towels.
- Low density polyethylene syringe with a smooth tapered hermetically sealed nozzle. Pack sizes: Cartons of 60 syringes including 60 individually wrapped teat cleaning towels.
- Low density polyethylene syringe with a smooth tapered hermetically sealed nozzle. Pack sizes: Cartons of 24 syringes including 24 individually wrapped teat cleaning towels.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories Limited
- Norbrook Manufacturing Limited
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/13/2183/001-003
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0587/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: